A relapse prevention study for anxiety patients who want to discontinue antidepressant medication.

The efficacy of a CBT relapse prevention program for remitted anxiety disorder patients who discontinue antidepressant medication (AD).

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON21398

Enrollment

220

Registered

2010-03-18

Start date

2010-03-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Remitted anxiety disorder patients: panic disorder with of without agoraphobia, social phobia and generalized anxiety disorder

Interventions

The intervention condition consists of 8 group sessions, each lasting two and a half hours, spread over 4 months. The intervention consists of CBT and discontinuation of AD. The control condition cons

Eligibility

Inclusion criteria

Inclusion criteria: Included are adults aged 18-65 years, who: 1. Use antidepressants for panic disorder (with or without agoraphobia), social phobia or generalized anxiety disorder; 2. Are in remission; 3. Want to discontinue antidepressant medication.

Exclusion criteria

Exclusion criteria: Patients with comorbid dementia, psychotic disorder, alcohol or drug dependence or who do not speak Dutch are excluded.

Design outcomes

Primary

Measure	Time frame
The primary outcome measure is relapse within a year.	—

Secondary

Measure	Time frame
1. Time to relapse; 2. One-year course of anxiety symptoms; 3. Quality of life; 4. Patient satisfaction; 5. Predictors of relapse; 6. Cost-effectivity; 7. Cost-utility.	—

Contacts

Public ContactW.D. Scholten

A.J. Ernststraat 887

w.scholten@ggzingeest.nl+31 (0)20 7884666

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)